Literature DB >> 3282649

Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin.

J F Moley1, S D Morrison, C M Gorschboth, J A Norton.   

Abstract

Exogenous insulin treatment has been shown to improve food intake and host weight of cachectic tumor-bearing (TB) rats, but the composition of the host weight gain has not been quantitated. Sixty-six Fischer 344 rats were randomized to seven groups: early nontumor-bearing (NTB) (n = 10) who underwent compositional analysis (CA) on the day the methylcholanthrene sarcoma was implanted in TB rats; pretreatment-NTB (n = 10) and pretreatment-TB (n = 10) who underwent CA 25 days later when rats began treatment with saline or insulin; and finally saline-treated NTB (n = 9), saline-treated TB (n = 9), insulin-treated NTB (n = 9), and insulin-treated TB (n = 9), who underwent CA following 5 days of treatment with daily saline or neutral protamine hagedorn insulin 2 units/100 g. Body weight and food intake were measured daily. For compositional analysis, the tumor was separated from the host in TB rats and the entire rat in NTB animals was homogenized, lyophilized and analyzed for fat, water, protein, potassium, chloride, and sodium. The tumor was processed in a similar fashion. In response to insulin, NTB rats ate significantly more food, and had an increase in body weight gain. Compositional analysis of insulin-treated NTB rats indicated a slight, but insignificant, increase in body fat and a similar insignificant decrease in body protein. TB rats ate significantly less than NTB rats during the 5-day experimental period, and insulin treatment significantly increased food intake to levels similar to NTB animals. Compositional analysis indicated that the tumor-bearing state resulted in a significant decrease in total host water, protein, fat, potassium, sodium, and chloride. Insulin administration resulted in preservation of host nitrogen, fat, potassium, sodium, and chloride in cachectic tumor-bearing rats. Insulin treatment did not affect tumor dry weight or composition. The results suggest that exogenous insulin, can preserve normal host composition of TB rats during cachectic decline.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3282649

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia.

Authors:  Michelle L Asp; Min Tian; Kara L Kliewer; Martha A Belury
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

2.  A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.

Authors:  Robert T Dauchy; Erin M Dauchy; Lulu Mao; Victoria P Belancio; Steven M Hill; David E Blask
Journal:  Comp Med       Date:  2012-04       Impact factor: 0.982

3.  Pharmacological interference with tissue hypercatabolism in tumour-bearing rats.

Authors:  L Tessitore; P Costelli; F M Baccino
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

4.  Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats.

Authors:  F M Tomas; C S Chandler; P Coyle; C S Bourgeois; J L Burgoyne; A M Rofe
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

5.  Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Horm Cancer       Date:  2013-10-08       Impact factor: 3.869

6.  Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

Authors:  P Costelli; C García-Martínez; M Llovera; N Carbó; F J López-Soriano; N Agell; L Tessitore; F M Baccino; J M Argilés
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

7.  The role of insulin resistance in the development of muscle wasting during cancer cachexia.

Authors:  Mary A Honors; Kimberly P Kinzig
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-12-01       Impact factor: 12.910

8.  Effect of insulin on weight loss and tumour growth in a cachexia model.

Authors:  S A Beck; M J Tisdale
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

Review 9.  Cancer cachexia.

Authors:  M J Tisdale
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

10.  Insulin-tumour interrelationships in EL4-lymphoma or thymoma-bearing mice. II. Effects of dietary omega-3 and omega-6 polyunsaturated fatty acids.

Authors:  D Yam; A Fink; I Nir; P Budowski
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.